Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.070
-0.030 (-2.73%)
At close: Aug 1, 2025, 4:00 PM
1.072
+0.002 (0.15%)
After-hours: Aug 1, 2025, 7:16 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Cellular Immunotherapies
63.53M
Log In
Log In
Log In
Log In
Upgrade
Cellular Immunotherapies Growth
-34.03%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
63.53M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-34.03%
Log In
Log In
Log In
Log In
Upgrade